Search Ontology:
ChEBI

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)

Term ID
CHEBI:78262
Synonyms
  • (2S,8R,13Z,16Z,19Z,22Z,25Z,28Z)-2-azaniumyl-8-[(hexadecanoyloxy)methyl]-5-oxido-10-oxo-4,6,9-trioxa-5-phosphahentriaconta-13,16,19,22,25,28-hexaen-1-oate 5-oxide
  • 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine
  • 1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)
  • 1-pamitoyl-2-docosahexaenoyl-sn-glycero-3-phosphoserine(1-)
Definition
A phosphatidylserine 38:6 that is the conjugate base of hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine; major species at pH 7.3.
References
Ontology
ChEBI  ( EBI )
Relationships
is a type of
inverse is_conjugate_acid_of
is_conjugate_base_of
Phenotype
Phenotype resulting from 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)
Phenotype where environments contain 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)
Phenotype modified by environments containing 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine(1-)
Human Disease Model